OneLife - "enzymes for patients' safety"

What we do: OneLife is a Belgian biomedical company dedicated to patient safety through innovative enzymatic decontamination solutions. We specialize in infection control and the disinfection of medical devices, focusing on hospitals, medical practices, and dental clinics. Our core products are advanced enzymatic cleaning solutions designed to detect and eliminate biofilms—bacterial nests that are a major source of healthcare-associated infections. By leveraging over 30 years of expertise from our parent company, REALCO SA, a global leader in enzymatic hygiene, we provide safe, effective, and environmentally friendly alternatives to traditional chemical detergents. Our mission is to reduce the risk of antimicrobial resistance (AMR) and healthcare-acquired infections (HAI), ensuring a safer environment for patients and healthcare professionals alike.

Where we are located: Our headquarters is located at Avenue Albert Einstein 15/1348, 1348 Ottignies-Louvain-la-Neuve, Belgium. This central location in the heart of Europe’s biotech hub allows us to collaborate closely with leading research institutions and healthcare providers.

Short history: OneLife was established in January 2015 as a spin-off from REALCO SA, capitalizing on decades of research and commercial experience in enzymatic hygiene. Since its founding, OneLife has focused on adapting REALCO’s proven enzyme technology for the medical sector, particularly for the cleaning of complex devices like endoscopes and surgical instruments. The company has grown through the support of both private and public investors, including a significant capital increase by REALCO in 2017 to accelerate development and market expansion.

Organization & culture: OneLife is a compact, dynamic team of 21 passionate professionals committed to excellence in infection control. Our culture is built on collaboration, innovation, integrity, and a strong commitment to public health. We value each team member’s contribution and believe that every individual plays a vital role in advancing patient safety worldwide. Our operations are certified according to ISO9001 and ISO13485 standards, reflecting our dedication to quality and environmental responsibility.

Recent developments: OneLife continues to innovate in the field of enzymatic decontamination, with ongoing research and product development aimed at addressing emerging challenges in healthcare hygiene. Our solutions are increasingly recognized as essential tools in the fight against biofilm-related infections and antimicrobial resistance, contributing to safer healthcare environments globally.